Roche Deutschland Holding GmbH
Germany
1 September 2020 - 31 August 2021
Parent institution: F. Hoffmann-La Roche AG
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Roche Deutschland Holding GmbH published between 1 September 2020 - 31 August 2021 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 11 | 3.14 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 10 | 2.74 | |
| Chemistry | 1 | 0.40 | |
Top articles by Altmetric score in current window
Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunities
Nature Communications
2020-11-13
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics
Science Translational Medicine
2020-10-14
Interplay between UNG and AID governs intratumoral heterogeneity in mature B cell lymphoma.
PLOS Genetics
2020-12-23
DutaFabs are engineered therapeutic Fab fragments that can bind two targets simultaneously
Nature Communications
2021-01-29
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
